VANCOUVER, British Columbia--(BUSINESS WIRE)--Feb. 15, 2006--PhytoMedical Technologies, Inc. (OTCBB:PYTO) (FWB:ET6): In Addition to Its Ongoing Diabetes and Cachexia Research, PhytoMedical Now Plans to Expand Its Activities to the Identification, Research and Development of Additional Plant Derived Compounds for Obesity, Cancer and Alzheimer’s Disease.
